A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis

Inclusion Criteria: * History (within the past 24 months) of allergic conjunctivitis. * Willing to avoid contact lens wear for each of the study visits, immediately prior to study medication installation and for 10 minutes after installation of study drug. * Contact lens wear should be stable and consistent for 3 months prior to Screening Visit (Day 1). * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Contraindications or hypersensitivity to the use of the study medication or its components. * Inability or unwillingness to follow all study instructions and complete study visits as required. * Subjects with only one sighted eye or not correctable (using ETDRS chart) to 0.6 log MAR or better in both eyes at the Screening Visit. * A known history of recurrent corneal erosion syndrome (idiopathic or secondary to dry eye). * Ocular trauma within six months prior to Visit 1 in either eye as determined by subject history and/or examination. * Other protocol-defined exclusion criteria may apply.